+

WO2001097791A3 - Utilisation d'acides en c4-c10 pour la prévention des infections a bactéries a gram négatif - Google Patents

Utilisation d'acides en c4-c10 pour la prévention des infections a bactéries a gram négatif Download PDF

Info

Publication number
WO2001097791A3
WO2001097791A3 PCT/FR2001/001971 FR0101971W WO0197791A3 WO 2001097791 A3 WO2001097791 A3 WO 2001097791A3 FR 0101971 W FR0101971 W FR 0101971W WO 0197791 A3 WO0197791 A3 WO 0197791A3
Authority
WO
WIPO (PCT)
Prior art keywords
acids
bacterial infections
negative bacterial
preventing gram
gram
Prior art date
Application number
PCT/FR2001/001971
Other languages
English (en)
Other versions
WO2001097791A2 (fr
Inventor
Michel Yvan Popoff
Original Assignee
Pasteur Institut
Michel Yvan Popoff
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR0007992A external-priority patent/FR2810546A1/fr
Application filed by Pasteur Institut, Michel Yvan Popoff filed Critical Pasteur Institut
Priority to US10/312,047 priority Critical patent/US20040116523A1/en
Priority to EP01947582A priority patent/EP1292291A2/fr
Priority to AU2001269239A priority patent/AU2001269239A1/en
Priority to CA002413284A priority patent/CA2413284A1/fr
Publication of WO2001097791A2 publication Critical patent/WO2001097791A2/fr
Publication of WO2001097791A3 publication Critical patent/WO2001097791A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Fodder In General (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

L'invention a pour objet l'utilisation d'acides en C4-C10 et/ou d'au moins l'un de leurs sels ou esters pour la préparation d'une composition pharmaceutique destinée à prévenir les infections à bactéries à Gram négatif, notamment à Salmonella.
PCT/FR2001/001971 2000-06-22 2001-06-22 Utilisation d'acides en c4-c10 pour la prévention des infections a bactéries a gram négatif WO2001097791A2 (fr)

Priority Applications (4)

Application Number Priority Date Filing Date Title
US10/312,047 US20040116523A1 (en) 2000-06-22 2001-06-22 Use of c4-c10 acids for preventing gram-negative bacterial infections
EP01947582A EP1292291A2 (fr) 2000-06-22 2001-06-22 Utilisation d'acides en c 4-c10 pour la prevention des infections a bacteries a gram-negatif
AU2001269239A AU2001269239A1 (en) 2000-06-22 2001-06-22 Use of c4-c10 acids for preventing gram-negative bacterial infections
CA002413284A CA2413284A1 (fr) 2000-06-22 2001-06-22 Utilisation d'acides en c4-c10 pour la prevention des infections a bacteries a gram negatif

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
FR00/07992 2000-06-22
FR0007992A FR2810546A1 (fr) 2000-06-22 2000-06-22 Utilisation d'acides en c2-c10 pour la prevention des infections a bacteries a gram negatif
FR0008383A FR2810547B1 (fr) 2000-06-22 2000-06-29 Utilisation d'acides en c2-c10 pour la prevention des infections a bacteries a gram negatif
FR00/08383 2000-06-29

Publications (2)

Publication Number Publication Date
WO2001097791A2 WO2001097791A2 (fr) 2001-12-27
WO2001097791A3 true WO2001097791A3 (fr) 2002-06-06

Family

ID=26212484

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/FR2001/001971 WO2001097791A2 (fr) 2000-06-22 2001-06-22 Utilisation d'acides en c4-c10 pour la prévention des infections a bactéries a gram négatif

Country Status (6)

Country Link
US (1) US20040116523A1 (fr)
EP (1) EP1292291A2 (fr)
AU (1) AU2001269239A1 (fr)
CA (1) CA2413284A1 (fr)
FR (1) FR2810547B1 (fr)
WO (1) WO2001097791A2 (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1291015A1 (fr) 2001-09-10 2003-03-12 Lunamed AG Compositions à libération prolongée d'un agent actif
WO2004103307A2 (fr) * 2003-05-20 2004-12-02 Baylor Research Institute Acides gras a cinq ou quinze carbones destines a traiter des troubles metaboliques et utilises comme complements nutritionnels
EP2237684A2 (fr) 2008-01-08 2010-10-13 Akthelia Pharmaceuticals Agonistes pour des systèmes peptidiques antimicrobiens
EP2215913A1 (fr) 2009-01-23 2010-08-11 Nutreco Nederland B.V. Additif d'aliment de bétail et aliment de bétail comprenant des esters alcoyls d'acides gras de longueur de chaîne intermédiaire, et leur utilisation dans les aliments de bétail
US9072296B2 (en) 2009-03-26 2015-07-07 Organic Medical Ventures, L.L.C. Transdermal venous access locking solutions
US20100249747A1 (en) * 2009-03-26 2010-09-30 Organic Medical Ventures, L.L.C. Transdermal venous access locking solution
US9433209B2 (en) 2009-03-26 2016-09-06 Organic Medical Ventures, L.L.C. Transdermal venous access locking solutions
US9427498B2 (en) 2009-03-26 2016-08-30 Organic Medical Ventures, L.L.C. Syringe treated with transdermal venous access locking solutions and method of treating the syringe
EP3220744A4 (fr) 2014-11-19 2018-08-01 Kansas State University Research Foundation Composés d'atténuation chimique dans l'alimentation animale et ingrédients pour l'alimentation animale
SE538436C2 (en) * 2014-12-09 2016-06-28 Perstorp Ab Composition inhibiting gram-negative pathogens in galloanserans

Citations (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2466663A (en) * 1944-10-20 1949-04-05 Ward Baking Co Fungicide containing caprylic acid and its salt
EP0021504A2 (fr) * 1979-06-25 1981-01-07 THE PROCTER & GAMBLE COMPANY Article utilisable comme cathéter ou analogue
US4406884A (en) * 1981-06-23 1983-09-27 The Procter & Gamble Company Topical antimicrobial composition
US4489097A (en) * 1976-07-28 1984-12-18 The Procter & Gamble Company Intravenous solutions with antimicrobial agent
JPS6453627A (en) * 1987-05-29 1989-03-01 Ricoh Kk Level shifter circuit device
JPH01153627A (ja) * 1987-12-10 1989-06-15 Nippo Kagaku Kk 毒素原性大腸菌症予防治療剤
US5234719A (en) * 1991-06-04 1993-08-10 Ecolab Inc. Food additive sanitizing compositions
JPH08325107A (ja) * 1995-06-01 1996-12-10 Takasago Internatl Corp 抗菌剤
WO1997000676A1 (fr) * 1995-06-21 1997-01-09 Oy Extracta Ltd. Composes antimicrobiens et anti-inflammatoires
WO1998003066A1 (fr) * 1996-07-19 1998-01-29 Kemira Chemicals Oy Composition antimicrobienne et procede de preparation
US6071961A (en) * 1995-11-28 2000-06-06 Wider; Michael D. Antimicrobial composition and methods of use therefor
WO2001097799A1 (fr) * 2000-06-20 2001-12-27 Nutrition Sciences Acides gras a chaines moyennes utilisables comme agents antimicrobiens

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8525061D0 (en) * 1985-10-10 1985-11-13 Bp Chem Int Ltd Antimicrobial additives
US5434182A (en) * 1987-12-31 1995-07-18 Isaacs; Charles E. Antibacterial fatty acid compositions
FI100376B (fi) * 1995-02-06 1997-11-28 Kemira Oyj Uusi säilöntäainekoostumus
DE19505518A1 (de) * 1995-02-10 1996-08-14 Ina Dr Levi Mittel zur Behandlung von Malaria, Hepatitis-B-Infektionen, Krebserkrankungen und systemischen opportunistischen Infektionen
US5965188A (en) * 1996-07-31 1999-10-12 Anitox Corporation Anti-bacterial amine derivatives
JPH11266796A (ja) * 1998-03-19 1999-10-05 Zenbi Shoji Kk 抗菌用飼料添加剤及び該抗菌用飼料添加剤を用いた抗菌方法

Patent Citations (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2466663A (en) * 1944-10-20 1949-04-05 Ward Baking Co Fungicide containing caprylic acid and its salt
US4489097A (en) * 1976-07-28 1984-12-18 The Procter & Gamble Company Intravenous solutions with antimicrobial agent
EP0021504A2 (fr) * 1979-06-25 1981-01-07 THE PROCTER & GAMBLE COMPANY Article utilisable comme cathéter ou analogue
US4406884A (en) * 1981-06-23 1983-09-27 The Procter & Gamble Company Topical antimicrobial composition
JPS6453627A (en) * 1987-05-29 1989-03-01 Ricoh Kk Level shifter circuit device
JPH01153627A (ja) * 1987-12-10 1989-06-15 Nippo Kagaku Kk 毒素原性大腸菌症予防治療剤
US5234719A (en) * 1991-06-04 1993-08-10 Ecolab Inc. Food additive sanitizing compositions
JPH08325107A (ja) * 1995-06-01 1996-12-10 Takasago Internatl Corp 抗菌剤
WO1997000676A1 (fr) * 1995-06-21 1997-01-09 Oy Extracta Ltd. Composes antimicrobiens et anti-inflammatoires
US6071961A (en) * 1995-11-28 2000-06-06 Wider; Michael D. Antimicrobial composition and methods of use therefor
WO1998003066A1 (fr) * 1996-07-19 1998-01-29 Kemira Chemicals Oy Composition antimicrobienne et procede de preparation
WO2001097799A1 (fr) * 2000-06-20 2001-12-27 Nutrition Sciences Acides gras a chaines moyennes utilisables comme agents antimicrobiens

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
DATABASE WPI Week 198930, Derwent World Patents Index; AN 1989-216462, XP002163939, TAKASHI KATSUO, FUJITA ITSUKI ET AL.: "Preventing and treating agent for enetrotoxigenic escherichia coli disease." *
PATENT ABSTRACTS OF JAPAN vol. 013, no. 417 *
PATENT ABSTRACTS OF JAPAN vol. 1997, no. 04 30 April 1997 (1997-04-30) *

Also Published As

Publication number Publication date
FR2810547B1 (fr) 2004-01-30
AU2001269239A1 (en) 2002-01-02
US20040116523A1 (en) 2004-06-17
CA2413284A1 (fr) 2001-12-27
FR2810547A1 (fr) 2001-12-28
WO2001097791A2 (fr) 2001-12-27
EP1292291A2 (fr) 2003-03-19

Similar Documents

Publication Publication Date Title
WO2001051456A3 (fr) Agents antibacteriens
CA2349161A1 (fr) Preparation pharmaceutique de moxifloxacine
AU2001262221A1 (en) Novel epothilone derivatives, method for the preparation thereof and their pharmaceutical use
IL151496A0 (en) Processes for preparing clarithromycin and clarithromycin intermediate, essentially oxime-free clarithromycin, and pharmaceutical composition comprising the same
HUP0103165A3 (en) Thiazoline acid derivatives, pharmaceutical compositions containig the same and their use
AU4930299A (en) Remedies for neuropathy containing as the active ingredient galectin-1 or its derivatives
WO2001097791A3 (fr) Utilisation d'acides en c4-c10 pour la prévention des infections a bactéries a gram négatif
AU2001232238A1 (en) Anti-acid-fast bacterial agents containing pyridonecarboxylic acids as the active ingredient
AU2000255628A1 (en) Formulation comprising thymol useful in the treatment of drug resistant bacterial infections
ZA200300743B (en) DDS compound and process for the preparation thereof.
AU2001232017A1 (en) Pharmaceutical composition for pulmonary delivery
AU7594301A (en) Derivatives of laspartomycin and preparation and use thereof
ZA200305877B (en) Novel pyrazine derivatives or salts thereof, pharmaceutical composition containing the same, and production intermediates thereof.
ZA200203078B (en) Ciclesonide-containing aqueous pharmaceutical composition.
AU1646701A (en) Composition for treating respiratory tract infections
WO2000010998A3 (fr) Antibiotique au pyridone a profil d'innocuite ameliore
AU3825700A (en) Pyrido-thieno-diazepines, method for the production thereof and pharmaceutical compositions containing said pyrido-thieno-diazepines
AU2001272695A1 (en) Azithromocin monohydrate with lower hygroscopicity, preparation method and pharmaceutical compositions which include it
AU5217401A (en) Novel l-form bacterial strains, method for producing same and the use thereof for producing gene products
AU2001282860A1 (en) Staphylococcus aureus ribosomal protein s20, corresponding gene and methods for the identification of antibacterial substances
AU4884701A (en) Malonanilic acid derivatives, medicinal compositions containing the same and usethereof
WO2002057281A3 (fr) Aminoglycosides utilises comme antibiotiques
CA2468036A1 (fr) Methode de traitement des infections bacteriennes a l'aide de gemifloxacine ou d'un sel de celle-ci et d'une .beta.-lactamine
CA2378537A1 (fr) Proteine de chlamysine b antibacterienne, gene codant pour cette proteine et systeme d'expression destines a cette proteine.
AU2001260083A1 (en) New pharmaceutical composition and the process for its preparation

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

WWE Wipo information: entry into national phase

Ref document number: 2001947582

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2413284

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 10312047

Country of ref document: US

WWP Wipo information: published in national office

Ref document number: 2001947582

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWW Wipo information: withdrawn in national office

Ref document number: 2001947582

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: JP

点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载